Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients

American Journal of Gastroenterology

Volumn 92, Issue 4, 1997, Pages 663-667

  Bianchi Porro, G ^a   Lazzaroni, M ^a   Petrillo, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; NAPROXEN; OMEPRAZOLE; RANITIDINE; SEROTONIN ANTAGONIST; SUCRALFATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCORING SYSTEM; STOMACH PROTECTION; STOMACH ULCER;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; DUODENAL ULCER; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MISOPROSTOL; NAPROXEN; OSTEOARTHRITIS; PLACEBOS; RANITIDINE; STOMACH ULCER;

EID: 0030945493     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Miller RR, Jick H. Acute toxicity of aspirin in hospitalized medical patients. Am J Med Sci 1977;274:271-9.
2. Dajani EZ, Agrawal NM. Protective effects of prostaglandins against non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Int J Clin Pharmacol 1989;4:359-69.
3. Caruso I, Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980;280:75-8.
4. Lanza FL, Royer GL, Nelson RS, et al. A comparative endoscopic evaluation of the damaging effect of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol 1981; 75:17-21.
5. Bianchi Porro G, Santalucia F. Sucralfate for NSAID-induced gastroduodenal lesions. In: Hollander D, Tytgat GNJ, eds. Sucralfate: From basic science to the bedside. New York and London: Plenum Med Co., 1995: 277-88.
6. Bianchi Porro G, Lazzaroni M. Prevention and treatment of nonsteroidal gastroduodenal lesions. Eur J Gastroenterol Hepatol 1993;5: 420-32.
7. Daneshmend TJ, Stein AG, Bhaskar NK, et al. Abolition by omeprazole of aspirin induced gastric injury in man. Gut 1990;31:514-9.
8. Oddsson E, Gudjonsson H, Thjodleifsson B. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Scand J Gastroenterol 1992;27:1045-8.
9. Lanza FL, Aspinall RL, Swabb EA, et al. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988;95:289-94.
10. Raskin JB, White JB, Jaszewski R, et al. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study. Am J Gastroenterol 1996;91:223-7.
11. Koch M, Capurso L, Dezi A, et al. Prevention of NSAID-induced gastroduodenal mucosal injury: Meta-analysis of clinical trials with misoprostol and H2-receptor antagonists. Dig Dis 1995;13(suppl 1): 62-74.
12. Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory drug-induced gastroduodenal ulceration. N Engl J Med 1992; 327:1575-90.
13. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized double-blind, placebo-controlled trial. Ann Intern Med 1995;123: 241-9.
14. Lanza FL, Fakouhi D, Rubin A, et al. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100 and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol 1989;84:633-6.
15. Jiranek GC, Kimmey MB, Saunders DR, et al. Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study. Gastroenterology 1989;96:656-61.
16. Aadland E, Fausa O, Vatn M, et al. Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med 1987;83(suppl 1A):37-40.
17. Lanza FL, Kochman RL, Geis GS, et al. Double-blind placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol 1991;86:1743-8.
18. Raskin JB, White RH, Jackson JE, et al. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: A comparison of three regimens. Ann Intern Med 1995;123:344-50.
19. Lanza F, Graham DY, Davis RE, Dack MF. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury: Effect of scoring method. Dig Dis Sci 1990; 35:1494-9.
20. Somasundaram S, Hayllar H, Rafi S, et al. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to gastrointestinal tract: A review and a hypothesis. Scand J Gastroenterol 1995;30: 289-99.
21. Scheiman JM. Pathogenesis of gastroduodenal injury due to nonsteroidal antimflammatory drugs: Implications for prevention and therapy. Semin Arthritis Rheum 1992;21:201-10.
22. Aabakken L, Larsen S, Osnes M. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by nonsteroidal, anti-inflammatory drugs. Scand J Rheumatol 1989;18:369-75.
23. Cole AT, Brundell S, Hudson N, et al. Ranitidine: Differential effects on gastric bleeding and mucosal damage induced by aspirin. Aliment Pharmacol Ther 1992;6:707-15.
24. Ehsanullah RSB, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: Controlled trial of ranitidine. Br Med J 1988;297:1017-21.
25. French P, Darekar BS, Mills JG, Wood JR. Ranitidine in the prevention of nonsteroidal anti-inflammatory drug-associated gastric and duodenal ulceration in arthritic patients. Eur J Gastroenterol Hepatol 1994; 6:1141-7.
26. Robinson MG, Griffin JW, Bowers J, et al. Griffin JW, Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs. Dig Dis Sci 1989;34(suppl 3):424-8.
27. Roth SH, Bennet RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal anti-inflammatory drugs gastropathy: Double-blind long-term evaluation. Arch Intern Med 1987;147:1798-801.
28. Muller P, Simon B. Schutzwitkung von ranitidin in magen und duodenum gegenuber piroxicam. Arzneimittelforschung/Drug Res 1992; 42:1492-4.
29. Muller P, Leucht U, Simon B. High-dose ranitidine protects stomach and duodenum completely against piroxicam: An endoscopic double-blind pilot study. Z Gastroentrerol 1992;30:851-3.
30. Ryan JR, Vargas R, Clay GA, McMahon FG. Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients. Am J Med 1987;83(suppl 1A):41-4.
31. Cohen MM, Clark L, Armstrong L, D'Souza J. Reduction of aspirin-induced fecal blood loss with low dose misoprostol tablets in man. Dig Dis Sci 1985;30:605-11.
32. Hunt JN, Smith JL, Jiang CL, Kessler MS. Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion. Dig Dis Sci 1983;28:897-902.
33. Silverstein FE, Kimmey MB, Saunders DR, Levine DS. Gastric protection by misoprostol against 1300 mg of aspirin: An endoscopic study. Dig Dis Sci 1986;31(suppl):137S-141S.
34. Bardhan KD, Griffin WM, Fenn GC, et al. Misoprostol protects against and reverses early nonsteroidal anti-inflammatory drug-induced mucosal damage. Gut 1991;32:A571.
35. Agrawal NM, Roth S, Graham DY, et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: A randomized, controlled trial. Ann Intern Med 1991;115:195-200.
36. Lichtenstein DR, Syngal S, Wolfe M. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Arthritis Rheum 1995;38:5-18.